Table 5 AI at baseline and after using wraparound (placebo) and percentage reduction of OSAS
From: Treatment of obstructive sleep apnea with oral appliances
Patient | AI | Reduction (%) | |
|---|---|---|---|
Baseline | After use | ||
1 | 6.4 | 6.0 | 6.4 |
2 | 2.3 | 0.4 | 84.1 |
3 | 2.1 | 0.4 | 82.9 |
4 | 4.9 | 11.6 | −137.1 |
5 | 1.6 | 6.3 | −301.9 |
6 | 16.3 | 22.6 | −38.4 |
7 | 6.3 | 23.2 | −269.9 |
8 | 2.1 | 0.5 | 75.7 |
9 | 9.3 | 0.8 | 91.3 |
10 | 1.2 | 2.6 | −119.3 |
11 | 3.1 | 0 | 100.0 |
12 | 4.1 | 11.2 | −172.4 |
13 | 13.9 | 0.6 | 95.9 |
14 | 8.1 | 13.7 | −68.5 |
15 | 2.0 | 0.7 | 66.0 |
16 | 1.9 | 2.4 | −25.7 |
17 | 3.7 | 0.6 | 84.3 |
18 | 15.2 | 26.0 | −71.0 |
19 | 3.3 | 13.0 | −296.0 |
Mean | 5.7 | 7.5 | −42.8 |
SD | 4.8 | 8.7 | 139.5 |